scispace - formally typeset
D

Dae Hyun Roh

Researcher at Kyung Hee University

Publications -  80
Citations -  2758

Dae Hyun Roh is an academic researcher from Kyung Hee University. The author has contributed to research in topics: Nociception & Neuropathic pain. The author has an hindex of 30, co-authored 77 publications receiving 2494 citations. Previous affiliations of Dae Hyun Roh include Seoul National University & Chonnam National University.

Papers
More filters
Journal ArticleDOI

Wound healing effect of silk fibroin/alginate-blended sponge in full thickness skin defect of rat

TL;DR: The results demonstrate that the wound healing effect of SF/AA is the best among other treatments including SF and AA, and this synergic effect is mediated by re-epithelialization via rapid proliferation of epithelial cell.
Journal ArticleDOI

Intrathecal injection of the ς1 receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain

TL;DR: Results demonstrate that spinal Sig-1Rs play a critical role in both the induction of mechanical allodynia and the activation of spinal N-methyl-d-aspartate receptors in CCI rats and suggest a potential therapeutic role for the use of Sig- 1R antagonists in the clinical management of neuropathic pain.
Journal ArticleDOI

Activation of the spinal sigma‐1 receptor enhances NMDA‐induced pain via PKC‐ and PKA‐dependent phosphorylation of the NR1 subunit in mice

TL;DR: It is demonstrated that the spinal sigma‐1 receptor (Sig‐1 R) plays an important role in pain transmission, although the exact mechanism is still unclear and there are no studies addressing whether Sig-1 R activation directly affects NMDA receptor sensitivity.
Journal ArticleDOI

Intrathecal treatment with σ1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice

TL;DR: It is suggested that selective blockage of spinal σ1 receptors can reduce pain behaviors, spinal cord Fos expression and pNR1 (Ser896 and Ser897) expression associated with the second phase of the formalin test.